Kalp Damar Cerrahisi Anestezisinde Kullanılan İnovatif Gelişmeler
Özet
Bu çalışma, kalp damar cerrahisi anestezisindeki inovatif yaklaşımları ve teknolojik gelişmeleri kapsamlı bir şekilde ele almaktadır. Başarılı bir operasyon süreci için preoperatif, intraoperatif ve postoperatif dönemlerin titizlikle dizayn edilmesi gerektiğini vurgulayan metin, temel olarak dört ana başlığa odaklanmaktadır. Preoperatif dönemde "kırılganlık indeksi" skorlamasının önemi belirtilerek; yaşlı hastalarda azalan fizyolojik rezervlerin mortalite ve morbidite riskini artırdığı, bu nedenle Fried ve Edmonton gibi testlerin prognostik değer taşıdığı ifade edilmektedir. Miyokard koruması başlığında ise artık sürecin sadece ameliyat anıyla sınırlı kalmadığı; kök hücre nakli, miRNA uygulamaları ve mitokondriyal fonksiyonların düzenlenmesi gibi ileri yöntemlerin kalp dokusunu korumada kritik rol oynadığı aktarılmaktadır. İlaç yönetiminde Omecamtiv mecarbil ve Istaroksim gibi yeni inotropik ajanlar ile volatil anesteziklerin kardiyoprotektif etkileri incelenmektedir. Cihazlar ve kanama yönetimi kısmında ise böbrek hasarını öngören Nephrocheck, serebral oksijenasyonu izleyen NIRS ve kanama kontrolünde standart testlerin ötesine geçen ROTEM/TEG algoritmaları üzerinde durulmaktadır. Sonuç olarak, teknolojik ürünlerin ve güncel protokollerin kullanımı, kalp cerrahisinde hasta güvenliğini ve hizmet kalitesini artıran temel unsurlar olarak sunulmaktadır.
This study comprehensively examines innovative approaches and technological advancements in cardiovascular surgery anesthesia. Emphasizing that preoperative, intraoperative, and postoperative periods must be meticulously designed for a successful operation, the text focuses on four main categories. In the preoperative period, the importance of "frailty index" scoring is highlighted, noting that decreased physiological reserves in elderly patients increase mortality and morbidity risks; thus, tests like Fried and Edmonton carry prognostic value. Under myocardial protection, it is stated that the process is no longer limited to the moment of surgery; advanced methods such as stem cell transplantation, miRNA applications, and the regulation of mitochondrial functions play a critical role in protecting heart tissue. In pharmacological management, new inotropic agents like Omecamtiv mecarbil and Istaroxime, along with the cardioprotective effects of volatile anesthetics, are analyzed. In the section on devices and bleeding management, Nephrocheck for predicting renal injury, NIRS for monitoring cerebral oxygenation, and ROTEM/TEG algorithms that go beyond standard tests for bleeding control are emphasized. In conclusion, the use of technological products and updated protocols are presented as fundamental elements that enhance patient safety and service quality in cardiac surgery.
Referanslar
Power I, Kam P.(2015). Yaşlanma Fizyolojisi. Prof. Dr. Ercan Kurt, Yrd.Doç.Dr. Ferruh Bilgin (Çeviri Editörleri), Anestezist için Temel Fizyoloji İlkeleri içinde (s.453-459).İstanbul:Habitat Yayıncılık
Preeya K. Mistry, Geoffrey S. Gaunay and David M. Hoenig, Prediction of surgical compilcations in elderly: Can we improve outcomes? Asian J Uro, 2017 Jan;4(1):44-49
Chow WB, Rosenthal RA, Merkow RP, et al. Optimal preoperative assessment of the geriatric surgical patient: a best practices guideline from the American College of Surgeons National Surgical Quality Improvement Program and the American Geriatrics Society. J Am Coll Surg, 2012;215(4):453-466
Afilalo J, Mottillo S, Eisenberg M.J, et al. Addition of Frailty and Disability to Cardiac Surgery Risk Scores Identifies Elderly Patients at High Risk of Mortality or Major Morbidity. Circulation: Cardiovascular Quality and Outcomes, 2012;5:222–228, doi.org/10.1161/CIRCOUTCOMES.111.963157
Godino C, Maisano F, Montorfano M,et al. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience. JACC Cardiovasc Interv, 2010 Nov;3(11):1110-21
Bakış LG, Osler TM, Neuman MD. Yüksek riskli hastalar için cerrahi karar vermeyi yeniden tasarlamak. N Engl J Med. 2014; 370 (15):1379-1381.
Stone L.L, Swingen C, Wright C, et al. Recovery of hibernating myocardium using stem cell patch with coronary bypass surgery. Basic Science. 2020;Volume 162, Issue 1, E3-E16, doi.org/10.1016/j.jtcvs.2019.12.073
Zhang G.Q, Wang S.Q, Chen Y,et al.Front. Pharmacol. 28 May 2021; 12: 663322. Published online 2021 May 28. doi: 10.3389/fphar.2021.663322
Maynard C, Fan J. (2017). Positive Inotropic Drugs and Drugs Used in Dysrhytmias.Volume 39.Side effects of Drugs Annual(173-178)
Shah S.J, Blai E.A, Gerasimos S.F, et al. Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: Results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial. American Heart Journal. Volume 157,Issue 6June 2009, Pages 1035-1041
Landoni G, Lomivorotov V.V, Neto C.N,et al. Volatile Anesthetics versus Total Intravenous Anesthesia for Cardiac Surgery N Engl J Med 2019; 380:1214-1225.
Oezkur M., Magyar A.,Thomas P. TIMP-2*IGFBP7 (Nephrocheck®) Measurements at Intensive Care Unit Admission After Cardiac Surgery are Predictive for Acute Kidney Injury Within 48 Hours Kidney Blood Press Res 2017;42:456–467
Arnab G, Clare E, Martin S,et al. Cerebral Near-Infrared Spectroscopy in Adults Anesthesia & Analgesia: December 2012-Volume 115-Issue 6- p 1373-1383
Hansson E.C, Hakimi C.S, Olsson K.A,et al. Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor Br J Anaesth2014 Mar;112(3):570-5
Zafar M.U, Smith D.A, Baber U, et al.Impact of Timing on the Functional Recovery Achieved With Platelet Supplementation After Treatment With TicagrelorCirculation: Cardiovascular Interventions. 2017;10:e005120
B.Schenk, Lindner A.K, Treichl B, et al.Fibrinogen supplementation ex vivo increasesclot firmness comparable to platelet transfusion in thrombocytopenia
Br J Anaesth. 2016 Nov;117(5):576-582.
